ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (953 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.pep.2007.06.003    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2007 Elsevier Inc. All rights reserved.

Profiling of membrane protein variants in a baculovirus system by coupling cell-surface detection with small-scale parallel expression

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Michael A. Hansona, Alexei Broounb, 1, Kent A. Bakerb, Veli-Pekka Jaakolaa, Chris Rotha, Ellen Y.T. Chiena, Alexander Alexandrova, Jeffrey Velasqueza, Leila Davisb, Mark Griffitha, Kin Moya, Barbie K. Ganser-Pornillosb, Yuanzi Huab, Peter Kuhnb, Sam Ellisc, Mark Yeagera, b, d and Raymond C. Stevensa, Corresponding Author Contact Information, E-mail The Corresponding Author

aDepartment of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, SR101, La Jolla, CA 92037, USA

bDepartment of Cell Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA

cThomson Instrument Company, 1121 South Cleveland Street, Oceanside, CA 92054, USA

dDivision of Cardiovascular Diseases, Scripps Clinic, La Jolla, CA 92037, USA


Received 26 April 2007; 
revised 12 June 2007. 
Available online 27 June 2007.

Abstract

Production of structure-grade mammalian membrane proteins in substantial quantities has been hindered by a lack of methods for effectively profiling multiple constructs expression in higher eukaryotic systems such as insect or mammalian cells. To address this problem, a specialized small-scale eukaryotic expression platform by Thomson Instrument Company (Vertiga-IM) was developed and used in tandem with a Guava EasyCyte microcapillary 96-well cytometer to monitor cell density and health and evaluate membrane protein expression. Two proof of concept experiments were conducted using the human β2-adrenergic receptor (β2AR) and the gap junction protein connexin26 (Cx26) in a baculovirus expression system. First, cell surface expression was used to assess the expression levels of 14 β2AR truncation variants expressed using the Vertiga-IM shaker. Three of these variants were then compared to wild-type β2AR using three metrics: cell surface expression, saturation ligand binding and protein immunoblot analysis of dodecylmaltoside extracted material. Second, a series of systematic Cx26 truncation variants were evaluated for expression by protein immunoblot analysis. The cumulative results for these two systems show that the Vertiga-IM instrument can be used effectively in the parallel insect cell microexpression of membrane protein variants, and that the expression of cell surface molecules as monitored with the Guava EasyCyte instrument can be used to rapidly assess the production of properly folded proteins in the baculovirus expression system. This approach expedites the in vitro evaluation of a large number of mammalian membrane protein variants.

Keywords: Membrane protein expression; Vertiga-IM; Microcapillary 96-well cytometer

Article Outline

Materials and methods
Construct design of human β2AR
Construct design of Cx26
Vertiga-IM development and expression of constructs
Flow cytometric analysis of β2AR cell surface expression
β2AR plasma membrane ligand binding assays
Western immunoblot analysis of total extractable material
Results
Protein expression
Cell surface expression of β2AR
Radioligand saturation binding assay for β2AR
Semi-quantitative Western immunoblot analysis of β2AR
Connexin truncation series
Discussion
Conclusions
Acknowledgements
Appendix A. Supplementary data
References






Corresponding Author Contact InformationCorresponding author. Fax: +1 858 784 9483.
1 Present address: Pfizer, Inc., 10770 Science Center Drive, CB2/2213, San Diego, CA 92121, USA.

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.